Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes
LEUKEMIA RESEARCH (2011)
期刊
LEUKEMIA RESEARCH
卷 35, 期 4, 页码 504-507出版社
PERGAMON-ELSEVIER SCIENCE LTD
关键词
作者
我是这篇论文的作者
推荐
High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes
Vladimir Riabov, Maximilian Mossner, Alexandra Stoehr, Johann-Christoph Jann, Alexander Streuer, Nanni Schmitt, Antje Knaflic, Verena Nowak, Nadine Weimer, Julia Oblaender, Iris Palme, Christiane Schumann, Claudia D. Baldus, Torsten J. Schulze, Patrick Wuchter, Henning Roehl, Ahmed Jawhar, Christel Weiss, Tobias Boch, Georgia Metzgeroth, Martin Neumann, Wolf-Karsten Hofmann, Florian Nolte, Daniel Nowak
BRITISH JOURNAL OF HAEMATOLOGY (2021)
The role of CD71+ erythroid cells in the regulation of the immune response
Tomasz M. Grzywa, Dominika Nowis, Jakub Golab
PHARMACOLOGY & THERAPEUTICS (2021)
TGSA: protein-protein association-based twin graph neural networks for drug response prediction with similarity augmentation
Yiheng Zhu, Zhenqiu Ouyang, Wenbo Chen, Ruiwei Feng, Danny Z. Chen, Ji Cao, Jian Wu
BIOINFORMATICS (2022)
Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome
Courtnee A. Clough, Joseph Pangallo, Martina Sarchi, Janine O. Ilagan, Khrystyna North, Rochelle Bergantinos, Massiel C. Stolla, Jasmine Naru, Patrick Nugent, Eunhee Kim, Derek L. Stirewalt, Arvind R. Subramaniam, Omar Abdel-Wahab, Janis L. Abkowitz, Robert K. Bradley, Sergei Doulatov
BLOOD (2022)
Meaningful response criteria for myelodysplastic syndromes
Nina Kim, Steven Pavletic, Kelly J. Norsworthy
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes
Shinpei Harada, Masahiro Onozawa, Daisuke Hidaka, Shota Yokoyama, Hajime Senjo, Shogo Takahashi, Reiki Ogasawara, Minoru Kanaya, Akio Mori, Shuichi Ota, Takeshi Kondo, Takanori Teshima
ANNALS OF HEMATOLOGY (2022)
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
Vincent G. Sorrentino, Srijan Thota, Edward A. Gonzalez, Pranela Rameshwar, Victor T. Chang, Jean-Pierre Etchegaray
PHARMACEUTICALS (2021)
CD36 relative mean fluorescence intensity of CD105(+) nucleated erythroid cells can be used to differentiate myelodysplastic syndrome from megaloblastic anemia
Yan Lu, Xuya Chen, Longyi Zhang
SCIENTIFIC REPORTS (2023)
DOT1L Methyltransferase Regulates Calcium Influx in Erythroid Progenitor Cells in Response to Erythropoietin
Yi Feng, Shaon Borosha, Anamika Ratri, Eun Bee Lee, Huizhen Wang, Timothy A. Fields, William H. Kinsey, Jay L. Vivian, M. A. Karim Rumi, Patrick E. Fields
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Stanozolol for the treatment of anemic lower-risk myelodysplastic syndromes without del(5q) after failure of epoetin alfa: findings from a retrospective study
Wei-ying Qu, Lin Zhao, Xv-cheng Tan, Yi-han Zhao
ANNALS OF HEMATOLOGY (2021)
Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival
Tianzeng Chen, Matthew Ho, Jenna Briere, Maria Moscvin, Peter G. Czarnecki, Kenneth C. Anderson, T. Keith Blackwell, Giada Bianchi
BLOOD ADVANCES (2022)
Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes
Yasunori Ueda, Kensuke Usuki, Jiro Fujita, Itaru Matsumura, Nobuyuki Aotsuka, Naohiro Sekiguchi, Tomonori Nakazato, Hiromi Iwasaki, Mariko Takahara-Matsubara, Saori Sugimoto, Masashi Goto, Tomoki Naoe, Masahiro Kizaki, Yasushi Miyazaki, Koichi Aakashi
CANCER SCIENCE (2022)
A machine learning model of response to hypomethylating agents in myelodysplastic syndromes
Nathan Radakovich, David A. Sallman, Rena Buckstein, Andrew Brunner, Amy Dezern, Sudipto Mukerjee, Rami Komrokji, Najla Al-Ali, Jacob Shreve, Yazan Rouphail, Anne Parmentier, Alexandre Mamedov, Mohammed Siddiqui, Yihong Guan, Teodora Kuzmanovic, Metis Hasipek, Babal Jha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Aziz Nazha
ISCIENCE (2022)
Rituximab-bortezomib-dexamethasone induce high response rates in iMCD in clinical practice
Xuejiao Yin, Yi Liu, Chengli Zhong, Yunfei Lv, Dan Xu, Li Zhu, Jie Jin, Haitao Meng, Liangshun You
BRITISH JOURNAL OF HAEMATOLOGY (2023)
PRMT5 regulates ovarian follicle development by facilitating Wt1 translation
Min Chen, Fangfang Dong, Min Chen, Zhiming Shen, Haowei Wu, Changhuo Cen, Xiuhong Cui, Shilai Bao, Fei Gao
ELIFE (2021)
Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia
Giovanni D'Arena, Silvestro Volpe, Rachele Amodeo, Virginia Tirino, Fiorella D'Auria, Giordano Annamaria, Giuseppe Pietrantuono, Luca Laurenti, Antonella Aiello, Pellegrino Musto
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2022)
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells
Giuseppe Ingravallo, Roberto Tamma, Giuseppina Opinto, Tiziana Annese, Francesco Gaudio, Giorgina Specchia, Tommasina Perrone, Pellegrino Musto, Gerardo Cazzato, Emilio Bellitti, Saverio Capodiferro, Eugenio Maiorano, Domenico Ribatti
DIAGNOSTICS (2022)
Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why?
Cosimo Cumbo, Luisa Anelli, Antonella Zagaria, Nicoletta Coccaro, Francesco Tarantini, Giorgina Specchia, Pellegrino Musto, Francesco Albano
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Tumor Microenvironment and Microvascular Density in Follicular Lymphoma
Roberto Tamma, Giuseppe Ingravallo, Tiziana Annese, Francesco Gaudio, Tommasina Perrone, Pellegrino Musto, Giorgina Specchia, Domenico Ribatti
JOURNAL OF CLINICAL MEDICINE (2022)
Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
Fiorella D'Auria, Teodora Statuto, Luciana Rago, Antonietta Montagna, Giovanni Castaldo, Irene Schiro, Anna Zeccola, Teresa Virgilio, Gabriella Bianchino, Antonio Traficante, Alessandro Sgambato, Vincenzo Fusco, Luciana Valvano, Giovanni Calice
FRONTIERS IN ONCOLOGY (2022)
Single-Cell Sequencing: Ariadne's Thread in the Maze of Acute Myeloid Leukemia
Immacolata Redavid, Maria Rosa Conserva, Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Pellegrino Musto, Francesco Albano
DIAGNOSTICS (2022)
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
Roberto Mina, Pellegrino Musto, Delia Rota-Scalabrini, Laura Paris, Barbara Gamberi, Angelo Palmas, Sara Aquino, Paolo de Fabritiis, Nicola Giuliani, Luca De Rosa, Alessandro Gozzetti, Claudia Cellini, Luca Bertamini, Andrea Capra, Daniela Oddolo, Iolanda Donatella Vincelli, Sonia Ronconi, Vincenzo Pavone, Norbert Pescosta, Michele Cea, Francesca Fioritoni, Stelvio Ballanti, Mariella Grasso, Elena Zamagni, Angelo Belotti, Mario Boccadoro, Francesca Gay
LANCET ONCOLOGY (2023)
The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms
Elisa Parciante, Cosimo Cumbo, Luisa Anelli, Antonella Zagaria, Immacolata Redavid, Angela Minervini, Maria Rosa Conserva, Giuseppina Tota, Nicoletta Coccaro, Francesco Tarantini, Crescenzio Francesco Minervini, Maria Giovanna Macchia, Giorgina Specchia, Pellegrino Musto, Francesco Albano
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
Maria Rosa Conserva, Immacolata Redavid, Luisa Anelli, Antonella Zagaria, Francesco Tarantini, Cosimo Cumbo, Giuseppina Tota, Elisa Parciante, Nicoletta Coccaro, Crescenzio Francesco Minervini, Angela Minervini, Giorgina Specchia, Pellegrino Musto, Francesco Albano
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Gordon Cook, Francesca Gay, Niels W. C. J. van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Fredrik Schjesvold, Claudio Cerchione, Sonja Zweegman, Roman Hajek, Philippe Moreau, Hermann Einsele, Jesus San-Miguel, Mario Boccadoro, Meletios A. A. Dimopoulos, Pieter Sonneveld, Heinz Ludwig
LEUKEMIA (2023)
Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study
Davide Fiore Bavaro, Lucia Diella, Alessandra Belati, Giuliana Metrangolo, Laura De Santis, Vito Spada, Michele Camporeale, Angelo Dargenio, Gaetano Brindicci, Flavia Balena, Deborah Fiordelisi, Fabio Signorile, Giacomo Loseto, Crescenza Pasciolla, Carla Minoia, Immacolata Attolico, Tommasina Perrone, Simona Simone, Maria Rendina, Nicoletta Giovine, Francesco Di Gennaro, Pellegrino Musto, Attilio Guarini, Alfredo Di Leo, Loreto Gesualdo, Maria Dell'Aera, Annalisa Saracino
VIRUSES-BASEL (2023)
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)
Esther Natalie Oliva, Anna Candoni, Prassede Salutari, Giuseppe A. Palumbo, Gianluigi Reda, Giuseppe Ianni, Giovanni Tripepi, Maria Cuzzola, Debora Capelli, Corrado Mammi, Caterina Alati, Maria Concetta Cannata, Pasquale Niscola, Bianca Serio, Pellegrino Musto, Ernesto Vigna, Antonio Volpe, Lorella Maria Antonia Melillo, Maria Teresa Arcadi, Donato Mannina, Maria Elena Zannier, Roberto Latagliata
CANCERS (2023)
The Tumor Microenvironment in Classic Hodgkin's Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy
Roberto Tamma, Giuseppe Ingravallo, Francesco Gaudio, Antonio d'Amati, Pierluigi Masciopinto, Emilio Bellitti, Loredana Lorusso, Tiziana Annese, Vincenzo Benagiano, Pellegrino Musto, Giorgina Specchia, Domenico Ribatti
CANCERS (2023)
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA
Nicoletta Coccaro, Luisa Anelli, Antonella Zagaria, Francesco Tarantini, Cosimo Cumbo, Giuseppina Tota, Crescenzio Francesco Minervini, Angela Minervini, Maria Rosa Conserva, Immacolata Redavid, Elisa Parciante, Maria Giovanna Macchia, Giorgina Specchia, Pellegrino Musto, Francesco Albano
DIAGNOSTICS (2023)
Interferon in chronic myeloid leukaemia: Is it useful for treatment-free remission?
Massimo Breccia, Giuseppe Saglio
BRITISH JOURNAL OF HAEMATOLOGY (2023)